We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
10 Year Est. Return
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
+$2.38M
Cap. Flow %
0.66%
Top 10 Hldgs %
7.17%
Holding
495
New
34
Increased
285
Reduced
131
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.11M
2
HSY icon
Hershey
HSY
+$2.09M
3
GILD icon
Gilead Sciences
GILD
+$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$2.13M
2
TKO icon
TKO Group
TKO
+$2.13M
3
WAT icon
Waters Corp
WAT
+$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

Rank Sector Weight
1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$167B
$2.85M 0.79%
20,473
+14,798
+261% +$2.07M
AMGN icon
2
Amgen
AMGN
$198B
$2.83M 0.78%
8,056
+5,906
+275% +$2.11M
REGN icon
3
Regeneron Pharmaceuticals
REGN
$70.9B
$2.78M 0.77%
3,598
+2,677
+291% +$2.05M
IBRX icon
4
ImmunityBio
IBRX
$8.04B
$2.74M 0.76%
357,747
+68,166
+24% +$467K
VRTX icon
5
Vertex Pharmaceuticals
VRTX
$123B
$2.62M 0.72%
5,869
+4,358
+288% +$2.03M
INCY icon
6
Incyte
INCY
$23.4B
$2.56M 0.71%
27,189
-785
-3% -$78.3K
VRT icon
7
Vertiv
VRT
$111B
$2.51M 0.69%
10,030
+21
+0.2% +$4.66K
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$35.7B
$2.47M 0.68%
7,471
+5,754
+335% +$1.96M
EIX icon
9
Edison International
EIX
$29.9B
$2.41M 0.67%
32,966
+30,284
+1,129% +$2.04M
ROST icon
10
Ross Stores
ROST
$74.9B
$2.21M 0.61%
10,202
-1,667
-14% -$332K
PWR icon
11
Quanta Services
PWR
$94.3B
$2.17M 0.6%
3,959
-380
-9% -$196K
DAWN
12
DELISTED
Day One Biopharmaceuticals
DAWN
$2.17M 0.6%
100,990
+19,243
+24% +$271K
BURL icon
13
Burlington
BURL
$21.7B
$2.13M 0.59%
6,546
-404
-6% -$124K
SLB icon
14
SLB Ltd
SLB
$70.3B
$2.12M 0.59%
41,285
+37,043
+873% +$1.8M
MRK icon
15
Merck
MRK
$315B
$2.12M 0.58%
+17,585
New +$2.03M
LIN icon
16
Linde
LIN
$237B
$2.08M 0.57%
+4,188
New +$1.98M
HSY icon
17
Hershey
HSY
$34.8B
$2.06M 0.57%
+9,903
New +$2.09M
CB icon
18
Chubb
CB
$137B
$2.05M 0.57%
+6,294
New +$2.02M
BKR icon
19
Baker Hughes
BKR
$55.5B
$2.05M 0.57%
33,588
-6,266
-16% -$362K
TJX icon
20
TJX Companies
TJX
$171B
$2.05M 0.56%
12,821
-423
-3% -$65.9K
WAB icon
21
Wabtec
WAB
$44.5B
$2.05M 0.56%
8,189
-1,445
-15% -$349K
WELL icon
22
Welltower
WELL
$172B
$2.04M 0.56%
10,342
-272
-3% -$53.8K
OXLC
23
Oxford Lane Capital
OXLC
$856M
$2.04M 0.56%
208,647
+58,756
+39% +$647K
HWM icon
24
Howmet Aerospace
HWM
$109B
$2.03M 0.56%
8,805
-683
-7% -$159K
ALL icon
25
Allstate
ALL
$64.3B
$2.02M 0.56%
9,743
-252
-3% -$51.7K

Similar funds

Virtus Investment Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Virtus Investment Advisers held 495 positions worth $363M, down 1.5% from $368M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Virtus Investment Advisers's Q1 2026 filing shows 34 new, 285 increased, 131 reduced and 45 closed positions. Its largest new stake was Hershey: 9,903 shares worth $2.06M. The largest sale was Huntington Bancshares, an estimated $2.13M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

  • Virtus Investment Advisers's largest Q1 2026 buy was Hershey: 9,903 shares worth $2.06M.
  • Virtus Investment Advisers added most to Amgen in Q1 2026, an estimated $2.11M increase.
  • Virtus Investment Advisers's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $1.56M.
  • Virtus Investment Advisers fully exited Huntington Bancshares in Q1 2026, selling an estimated $2.13M.
  • Virtus Investment Advisers's ten largest holdings make up 7.2% of its $363M portfolio in Q1 2026.
  • Virtus Investment Advisers opened 34 new positions and closed 45 in Q1 2026.
  • Virtus Investment Advisers's portfolio value fell 1.5% quarter-over-quarter to $363M.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.